|
Status |
Public on Aug 21, 2017 |
Title |
MOLM13-0-hrs-18 |
Sample type |
SRA |
|
|
Source name |
Myeloid leukemia cell
|
Organism |
Homo sapiens |
Characteristics |
cancer type: Leukemia cell type: Human myeloid cell time: 0h dox: N/A
|
Treatment protocol |
Human cell lines were treated with vitamin C in culture for 0, 12 and 72hrs. Mouse progenitors were treated with 1ug/ml Doxycycline to turn off Tet2 shRNA expression for 14 days
|
Growth protocol |
Human cell lines were grown in RPMI media with 10-20% FBS, mouse progenitors were cultured in Optimem media supplemented with 10%FBS and SCF, IL3 and IL6 cytokines
|
Extracted molecule |
total RNA |
Extraction protocol |
RNA was isolated from cells according to the RNeasy Qiagen Kit protocol RNA libraries were prepared for sequencing using standard Illumina protocols
|
|
|
Library strategy |
RNA-Seq |
Library source |
transcriptomic |
Library selection |
cDNA |
Instrument model |
Illumina HiSeq 2500 |
|
|
Data processing |
Base calling and demultiplexing was performed using Illumina bcl2fastq software. The sequencing reads were aligned to the human and mouse genomes (build hg19/GRCh37 and mm10/GRCm38, respectively) using the splice-aware STAR aligner. The featureCounts program was utilized to generate counts for each gene. The raw counts were normalized using the DESeq2 R package. Genome_build: hg19 and mm10 Supplementary_files_format_and_content: CSV files contain raw and normalized counts for all genes and samples.
|
|
|
Submission date |
Apr 05, 2017 |
Last update date |
May 15, 2019 |
Contact name |
Igor Dolgalev |
Organization name |
NYU Grossman School of Medicine
|
Street address |
550 1st Ave
|
City |
New York |
State/province |
New York |
ZIP/Postal code |
10016 |
Country |
USA |
|
|
Platform ID |
GPL16791 |
Series (2) |
GSE97440 |
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors |
GSE97442 |
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia |
|
Relations |
BioSample |
SAMN06689228 |
SRA |
SRX2711380 |